July 31, 2018 Chromatography Clinical Research/Diagn. Lab Top-10 Mass Spectrometry Product Launch

New Triple Quadrupole Mass Spectrometer offers Robust and Fast Analysis with LC-MS/MS for Clinical Research Laboratories

New Triple Quadrupole Mass Spectrometer offers Robust and Fast Analysis with LC-MS/MS for Clinical Research Laboratories Robust Thermo Scientific TSQ Fortis Triple Quadrupole mass spectrometer designed for productivity across all levels of users CHICAGO – AACC – (July 31, 2018) – Scientists in clinical research laboratories facing challenges in developing robust, reproducible, and reliable methods... Read more

July 31, 2018 Clinical Research/Diagn. Lab Top-10 PR/Corporate

Thermo Fisher Scientific Showcases Innovations for Research and Clinical Labs at AACC 2018

CHICAGO, July 31, 2018 /PRNewswire/ — AACC — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, is showcasing its latest innovations for clinical and translational research during the 2018 American Association of Clinical Chemistry (AACC) Annual Scientific Meeting & Clinical Lab Expo (booth 3831), being held July 29 – August 2 at McCormick Place... Read more

July 31, 2018 Clinical Research/Diagn. Lab Equipment Lab Top-10 Product Launch

New Compact Refrigerators Designed for Secure and Sustainable Clinical Storage

The Thermo Scientific TSG Series of refrigerators maintain optimal cold storage conditions with minimal energy consumption and noise output CHICAGO, July 31, 2018 /PRNewswire/ — AACC — A new series of compact refrigerators has been specifically developed to address the need of clinical laboratories and patient care facilities for cold storage equipment that enable secure and... Read more

July 31, 2018 Clinical Research/Diagn.

GE Healthcare and Lantheus Announce Start of a Phase 3 Clinical Trial of Flurpiridaz, an Investigational Agent Being Evaluated for the Detection of Coronary Artery Disease

Boston and North Billerica, MA, USA – July 31, 2018 – GE Healthcare and Lantheus Holdings, Inc. (NASDAQ: LNTH), parent company of Lantheus Medical Imaging, Inc. (collectively “Lantheus”), have started a second Phase 3 clinical trial of Flurpiridaz 18F (called the AURORA study), an investigational agent being evaluated for the detection of coronary artery disease... Read more

July 31, 2018 Clinical Research/Diagn. Lab Top-10 Liq. Handling & Robotics PR/Corporate Product Launch

New Phadia 200 Advances In-vitro Diagnostics in Europe for Allergy and Autoimmune Conditions

CHICAGO – AACC – (July 31, 2018) – A new benchtop instrument from Thermo Fisher Scientific, the Phadia 200, enables new levels of flexibility and automation for laboratory testing facilities to aid in the diagnosis of allergy and autoimmunity conditions. The Phadia 200 is CE-marked, and the first installations are underway at select European sites.... Read more

July 31, 2018 Cell Analysis Tools Clinical Research/Diagn. Lab Top-10 PR/Corporate Product Launch

New Compounds Now Available for Antimicrobial Susceptibility Testing: Delafloxacin and Meropenem/Vaborbactam

FDA-cleared microbroth dilution plates provide true minimum inhibitory concentration (MIC) results, facilitating more targeted patient therapy CHICAGO – AACC – (July 31, 2018) – The antimicrobial delafloxacin, and the combination of meropenem and vaborbactam are now available on FDA-cleared microbroth dilution susceptibility plates. Delafloxacin is available for testing select fastidious and non-fastidious Gram positive and... Read more

July 31, 2018 Cell Analysis Tools Clinical Research/Diagn. Life Science Tools M&A, Partnerships

10x Genomics Partners with BioLegend and Immudex to Extend Research Applications of Its New Single Cell Feature Barcoding Technology

PLEASANTON, CA.—July 31, 2018—10x Genomics, Inc., a company focused on accelerating genomic discovery, today announced that BioLegend and Immudex will be the first 10x Compatible Partners providing products for its new single cell Feature Barcoding Technology, which was revealed at the 2018 Advances in Genome Biology and Technology meeting in February this year. The resulting product innovations, available at the end of... Read more

July 30, 2018 Bio/Pharma/CRO Clinical Research/Diagn. M&A, Partnerships

Forbes Insights and IDEX Health & Science LLC Report Finds Life Science Sector is ‘Behind’ the Collaboration Curve

Rohnert Park, CA, July 30, 2018 — A survey of three technology-intensive industries has found a growing share of executives, including 68% of life science executives, see active and meaningful collaboration with their suppliers as essential to their future success/innovation/competitive advantage. 180 executives from the life science, pharmaceuticals, and aviation industries took part in the... Read more

July 30, 2018 Acad, Gov/Utilities Clinical Research/Diagn. M&A, Partnerships

QIAGEN’s QuantiFERON-TB® Gold Plus wins UN migration agency’s tender

Hilden, Germany, and Germantown, Maryland, July 30, 2018 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that QuantiFERON-TB® Gold Plus (QFT-Plus), the gold standard in accurate, cost-effective testing for latent tuberculosis (TB) infection, has been adopted by the International Organization for Migration (IOM) for use in screening migrants for the infection. As the United... Read more